Baxter follows the rigorous US Food and Drug Administration (FDA) and European Medicines Agency (EMEA) policies and criteria for plasma donation centers. Baxter also voluntarily complies with the Plasma Protein Therapeutics Association (PPTA), PPTA’s International Quality Plasma Program (IQPP), Occupational Safety and Health Administration (OSHA), and Clinical Laboratory Improvement Amendment (CLIA) standards to safeguard the collection of plasma used for plasma-derived therapies.
A sterile, nonpyrogenic preparation of albumin in a single-dosage
Sterile, stable, lyophilized preparation of purified alpha 1-proteinase inhibitor
